Sort:
Open Access Rapid Communication Issue
NAD+ supplementation augments the efficacy of the PARP1 inhibitor PJ34 in a 6-OHDA-induced model of Parkinson’s disease
Genes & Diseases 2026, 13(2)
Published: 25 July 2025
Abstract PDF (4.4 MB) Collect
Downloads:3
Total 1